In a filing, Jazz Pharmaceuticals plc revealed its Director COZADD BRUCE C unloaded Company’s shares for reported $0.49 million on Oct 03 ’25. In the deal valued at $140.00 per share,3,500 shares were sold. As a result of this transaction, COZADD BRUCE C now holds 408,826 shares worth roughly $56.25 million.
Then, COZADD BRUCE C sold 2,000 shares, generating $263,560 in total proceeds. Upon selling the shares at $131.78, the Director now owns 412,326 shares.
Before that, Bruce C Cozadd bought 3,500 shares. Jazz Pharmaceuticals plc shares valued at $490,000 were divested by the Officer at a price of $140.00 per share.
Deutsche Bank initiated its Jazz Pharmaceuticals plc [JAZZ] rating to a Buy in a research note published on July 15, 2025; the price target was $152. A number of analysts have revised their coverage, including UBS’s analysts, who increased its forecast for the stock in early March from “a Neutral” to “a Buy”. Cantor Fitzgerald also remained covering JAZZ and has decreased its forecast on February 26, 2025 with a “Neutral” recommendation from previously “an Overweight” rating. Wells Fargo revised its rating on February 13, 2025. It rated JAZZ as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of JAZZ
On Monday, Jazz Pharmaceuticals plc [NASDAQ:JAZZ] saw its stock fall -1.36% to $137.58. Over the last five days, the stock has gained 6.63%. Jazz Pharmaceuticals plc shares have risen nearly 25.41% since the year began. Nevertheless, the stocks have risen 11.72% over the past one year. While a 52-week high of $148.06 was reached on 02/26/25, a 52-week low of $95.49 was recorded on 04/09/25.
Levels Of Support And Resistance For JAZZ Stock
The 24-hour chart illustrates a support level at 136.59, which if violated will result in even more drops to 135.60. On the upside, there is a resistance level at 138.98. A further resistance level may holdings at 140.38.
How much short interest is there in Jazz Pharmaceuticals plc?
A steep rise in short interest was recorded in Jazz Pharmaceuticals plc stocks on 2025-09-15, dropping by -0.32 million shares to a total of 5.3 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 5.62 million shares. There was a decline of -6.05%, which implies that there is a negative sentiment for the stock.
